Biocon continues expanding its biosimilar and specialty healthcare business across international markets. Growing demand for affordable biologic medicines is supporting opportunities in the biotechnology sector.
The company is investing in research, regulatory approvals, and manufacturing capabilities to strengthen its global position. Increasing healthcare awareness and rising chronic disease treatment demand are also benefiting the industry.
Experts believe biotechnology and specialty pharma companies may continue witnessing strong growth due to innovation-driven healthcare demand.
